RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: all available years, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD Q93.5ORPHA:261265

17q12 Microdeletion Syndrome

17q12 microdeletion syndrome is a rare genetic condition caused by a missing piece of chromosome 17. It commonly affects the kidneys, causing cysts or abnormal kidney development, and can lead to early-onset diabetes. Some people also have developmental delay, learning difficulties or autism. Care is shared between kidney, hormone and developmental specialists and is tailored to each person.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

17q12 Microdeletion Syndrome is very rare and little research has been published, so this page includes research from every year, including case reports about individual patients. Case reports are marked, and describe one person's experience rather than tested results.

115
Articles
—
Trials
Data refreshed
27 September 2026
Loading...

Common Questions

What is 17q12 Microdeletion Syndrome?

17q12 microdeletion syndrome is a rare genetic condition caused by a missing piece of chromosome 17. It commonly affects the kidneys, causing cysts or abnormal kidney development, and can lead to early-onset diabetes. Some people also have developmental delay, learning difficulties or autism. Care is shared between kidney, hormone and developmental specialists and is tailored to each person.

How many clinical trials are available for 17q12 Microdeletion Syndrome?

No clinical trials are currently indexed for 17q12 Microdeletion Syndrome. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.

Where does the research data for 17q12 Microdeletion Syndrome come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for 17q12 Microdeletion Syndrome.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.